PL3548016T3 - MODULATORY ROR-GAMMA (RORγ) - Google Patents

MODULATORY ROR-GAMMA (RORγ)

Info

Publication number
PL3548016T3
PL3548016T3 PL17826439T PL17826439T PL3548016T3 PL 3548016 T3 PL3548016 T3 PL 3548016T3 PL 17826439 T PL17826439 T PL 17826439T PL 17826439 T PL17826439 T PL 17826439T PL 3548016 T3 PL3548016 T3 PL 3548016T3
Authority
PL
Poland
Prior art keywords
rory
ror
modulators
gamma
Prior art date
Application number
PL17826439T
Other languages
English (en)
Inventor
Joseph Maria Gerardus Barbara Cals
David Machnik
Sander Bernardus NABUURS
Jean-François SABUCO
Original Assignee
Lead Pharma B.V.
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Pharma B.V., Sanofi filed Critical Lead Pharma B.V.
Publication of PL3548016T3 publication Critical patent/PL3548016T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL17826439T 2016-12-05 2017-12-05 MODULATORY ROR-GAMMA (RORγ) PL3548016T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16202175 2016-12-05
EP17826439.6A EP3548016B1 (en) 2016-12-05 2017-12-05 Ror-gamma (rory)-modulators
PCT/EP2017/081489 WO2018104288A1 (en) 2016-12-05 2017-12-05 ROR gamma (RORy) modulators

Publications (1)

Publication Number Publication Date
PL3548016T3 true PL3548016T3 (pl) 2021-02-08

Family

ID=57482312

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17826439T PL3548016T3 (pl) 2016-12-05 2017-12-05 MODULATORY ROR-GAMMA (RORγ)

Country Status (34)

Country Link
US (3) US10196350B2 (pl)
EP (1) EP3548016B1 (pl)
JP (1) JP6955563B2 (pl)
KR (1) KR102554776B1 (pl)
CN (1) CN110352054B (pl)
AR (1) AR110481A1 (pl)
AU (1) AU2017373593B2 (pl)
BR (1) BR112019010461A2 (pl)
CA (1) CA3045946A1 (pl)
CL (1) CL2019001406A1 (pl)
CO (1) CO2019007186A2 (pl)
CR (1) CR20190321A (pl)
DK (1) DK3548016T3 (pl)
DO (1) DOP2019000119A (pl)
EA (1) EA201991373A1 (pl)
EC (1) ECSP19047767A (pl)
ES (1) ES2830759T3 (pl)
HU (1) HUE052470T2 (pl)
IL (1) IL267045B (pl)
LT (1) LT3548016T (pl)
MA (1) MA46965B1 (pl)
MX (1) MX2019006517A (pl)
MY (1) MY194174A (pl)
NZ (1) NZ755105A (pl)
PE (1) PE20191545A1 (pl)
PH (1) PH12019501231A1 (pl)
PL (1) PL3548016T3 (pl)
PT (1) PT3548016T (pl)
RS (1) RS60964B1 (pl)
TW (1) TWI705958B (pl)
UA (1) UA123751C2 (pl)
UY (1) UY37507A (pl)
WO (1) WO2018104288A1 (pl)
ZA (1) ZA201902288B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3101009A1 (en) 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
UY37507A (es) 2016-12-05 2018-06-29 Lead Pharma Holding Bv Moduladores de ror gamma (ror¿)
WO2023232870A1 (en) 2022-05-31 2023-12-07 Immunic Ag Rorg/rorgt modulators for the treatment of virus infections like covid-19

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1771204A4 (en) 2004-07-01 2008-08-13 Univ New York COMPOSITIONS AND METHODS FOR MODULATING ROR GAMMA T
WO2011115892A1 (en) * 2010-03-15 2011-09-22 Griffin Patrick R Modulators of the retinoic acid receptor-related orphan receptors
WO2013029338A1 (en) * 2011-09-01 2013-03-07 Glaxo Group Limited Novel compounds
EP2847198B1 (en) 2012-05-08 2016-12-14 Lycera Corporation Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease
WO2013171729A2 (en) * 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl amide compounds as rorgamat modulator
US9359315B2 (en) 2013-09-10 2016-06-07 Arrien Pharmaceuticals Llc Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
DK3077372T3 (en) 2013-12-05 2019-04-23 Lead Pharma Holding Bv ROR GAMMA MODULATORS
TW201605797A (zh) 2013-12-10 2016-02-16 葛蘭馬克製藥公司 作為ror伽馬調節物的雙環雜芳基化合物
CA2934378C (en) 2013-12-19 2022-03-22 Merck Patent Gmbh Tetrahydro-tetrazolo[1 ,5-a]pyrazines as ror-gamma inhibitors
WO2015101928A1 (en) 2013-12-31 2015-07-09 Aurigene Discovery Technologies Limited Fused thiophene and thiazole derivatives as ror gamma modulators
MX371017B (es) 2014-02-03 2020-01-13 Vitae Pharmaceuticals Llc Inhibidores de dihidropirrolopiridina de receptor huerfano relacionado-gamma.
NZ724602A (en) 2014-03-27 2022-12-23 Piramal Entpr Ltd Ror-gamma modulators and uses thereof
BR112016021962A2 (pt) 2014-04-14 2023-01-20 Boehringer Ingelheim Int Compostos, composição farmacêutica e seus usos como moduladores de ror gama
HUE054009T2 (hu) 2015-05-15 2021-08-30 Aurigene Discovery Tech Ltd Szubsztituált tetrahidrokinolinon vegyületek ROR gamma modulátorként
EP3101007A1 (en) 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
EP3101008A1 (en) 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
EP3101009A1 (en) 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
EP3101006A1 (en) 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
EP3101005A1 (en) 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
HUE048902T2 (hu) 2015-08-03 2020-08-28 Glenmark Pharmaceuticals Sa Új ROR gamma modulátor vegyületek
WO2017213137A1 (ja) 2016-06-09 2017-12-14 アグロカネショウ株式会社 新規化合物およびこれを有効成分とする農園芸用薬剤
UY37507A (es) 2016-12-05 2018-06-29 Lead Pharma Holding Bv Moduladores de ror gamma (ror¿)
JP2019026575A (ja) 2017-07-27 2019-02-21 アグロカネショウ株式会社 新規化合物およびこれを有効成分とする農園芸用殺菌剤

Also Published As

Publication number Publication date
JP6955563B2 (ja) 2021-10-27
ES2830759T3 (es) 2021-06-04
AR110481A1 (es) 2019-04-03
ECSP19047767A (es) 2019-08-30
KR102554776B1 (ko) 2023-07-11
NZ755105A (en) 2023-01-27
EP3548016A1 (en) 2019-10-09
UY37507A (es) 2018-06-29
CA3045946A1 (en) 2018-06-14
CR20190321A (es) 2019-09-11
EA201991373A1 (ru) 2019-11-29
TWI705958B (zh) 2020-10-01
HUE052470T2 (hu) 2022-02-28
AU2017373593A1 (en) 2019-07-25
TW201835038A (zh) 2018-10-01
US20200190028A1 (en) 2020-06-18
ZA201902288B (en) 2020-10-28
DK3548016T3 (da) 2020-11-16
MY194174A (en) 2022-11-17
CN110352054B (zh) 2022-11-01
CO2019007186A2 (es) 2019-08-20
IL267045A (en) 2019-07-31
JP2020500886A (ja) 2020-01-16
CN110352054A (zh) 2019-10-18
MA46965B1 (fr) 2020-12-31
RS60964B1 (sr) 2020-11-30
US20180162808A1 (en) 2018-06-14
IL267045B (en) 2021-07-29
US11299456B2 (en) 2022-04-12
LT3548016T (lt) 2021-01-11
KR20190096365A (ko) 2019-08-19
CL2019001406A1 (es) 2019-10-18
EP3548016B1 (en) 2020-09-02
PH12019501231A1 (en) 2019-09-23
AU2017373593B2 (en) 2022-04-07
MX2019006517A (es) 2019-08-22
US10196350B2 (en) 2019-02-05
WO2018104288A1 (en) 2018-06-14
PE20191545A1 (es) 2019-10-24
BR112019010461A2 (pt) 2019-09-10
DOP2019000119A (es) 2019-09-30
PT3548016T (pt) 2020-10-08
US20190119204A1 (en) 2019-04-25
UA123751C2 (uk) 2021-05-26

Similar Documents

Publication Publication Date Title
DK3512547T3 (en) Anti-pd-1-antistoffer
AU201616678S (en) Cylindres
DK3504696T3 (en) Optisk kommunikativt batteristyringssystem
DK3482386T3 (en) Patientsimulator
DK3438253T3 (en) Phytasemutant
EP3445380C0 (en) BACTERIOTHERAPY
DK3270751T3 (en) Foodprocessor
DK3538786T3 (en) Friktionsmateriale
DK3544712T3 (en) Filtersystem
DK3440392T3 (en) Styreapparat
HUE052470T2 (hu) ROR-gamma (RORy) modulátorok
GB201600289D0 (en) Polydendrons
DK3468998T3 (en) Anti-tnfrsf25-antistoffer
PL3516135T3 (pl) Okucie
AU201710564S (en) Bookrack
DK3430092T3 (en) Coatingsystem
AU201713059S (en) SUNSHADE - square
AU201713060S (en) SUNSHADE - triangle
GB2591055B (en) Fitting
AU5499P (en) T15-1218 Bituminaria bituminosa
AU2016376V (en) NinbellaPurple Alyogyne huegelii
AU2016362V (en) JCU9 Desmanthus pernambucanus
AU2016361V (en) JCU8 Desmanthus virgatus
AU2016360V (en) JCU7 Desmanthus leptophyllus
AU2016359V (en) JCU6 Desmanthus bicornutus